World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
106
Citations
35701
World Ranking
6606
National Ranking
196

Overview

Erwan Bezard is affiliated with the University of Bordeaux in France. Their research primarily focuses on medicine and neuroscience, with a considerable emphasis on neurology and cellular and molecular neuroscience. The scope of their work also spans physiology, molecular biology, and biomedical engineering.

The scientist's main research topics include:

  • Parkinson's Disease Mechanisms and Treatments
  • Neurological disorders and treatments
  • Alzheimer's disease research and treatments
  • Neuroscience and Neuropharmacology Research
  • Botulinum Toxin and Related Neurological Disorders
  • Neuroscience and Neural Engineering
  • Nuclear Receptors and Signaling

Bezard has published extensively, including recent papers such as:

  • Motor and non-motor circuit disturbances in early Parkinson disease: which happens first? (2021) in Nature Reviews. Neuroscience
  • Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates (2020) in Brain
  • Neuroprosthetic baroreflex controls haemodynamics after spinal cord injury (2021) in Nature
  • Soft, Implantable Bioelectronic Interfaces for Translational Research (2020) in Advanced Materials
  • Synucleinopathy alters nanoscale organization and diffusion in the brain extracellular space through hyaluronan remodeling (2020) in Nature Communications

Frequent coauthors collaborating with Bezard include:

  • Benjamin Dehay
  • Marie-Laure Arotçarena
  • Sandra Doveró
  • Évelyne Doudnikoff
  • Florent Laferrière

Bezard's work appears regularly in several publication venues, such as:

  • Neurobiology of Disease
  • bioRxiv (Cold Spring Harbor Laboratory)
  • npj Parkinson's Disease
  • Science Advances
  • Movement Disorders

Best Publications

  • Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms

    Maria C Rodriguez-Oroz;Maria C Rodriguez-Oroz;Marjan Jahanshahi;Paul Krack;Paul Krack;Irene Litvan

  • Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy

    J.A. Obeso;M. Stamelou;M. Stamelou;C.G. Goetz;W. Poewe

  • A brain–spine interface alleviating gait deficits after spinal cord injury in primates

    Marco Capogrosso;Tomislav Milekovic;David Borton;David Borton;Fabien Wagner

  • Lewy body extracts from Parkinson disease brains trigger α‐synuclein pathology and neurodegeneration in mice and monkeys

    Ariadna Recasens;Benjamin Dehay;Jordi Bové;Iria Carballo-Carbajal

  • Relationship between the Appearance of Symptoms and the Level of Nigrostriatal Degeneration in a Progressive 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Macaque Model of Parkinson's Disease

    Erwan Bezard;Erwan Bezard;Sandra Dovero;Caroline Prunier;Paula Ravenscroft

  • Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies

    Erwan Bezard;Jonathan M. Brotchie;Christian E. Gross

  • Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations

    Benjamin Dehay;Mathieu Bourdenx;Philippe Gorry;Serge Przedborski

  • Priorities in Parkinson's disease research

    Wassilios G Meissner;Wassilios G Meissner;Mark Frasier;Thomas Gasser;Christopher G Goetz

  • Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease.

    Matthieu F. Bastide;Wassilios G. Meissner;Barbara Picconi;Stefania Fasano

  • Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia.

    Incarnation Aubert;Céline Guigoni;Kerstin Håkansson;Qin Li

  • Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function.

    Erwan Bézard;Sandrine Ferry;Ulrich Mach;Holger Stark

  • Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing

    Barry Boland;Wai Haung Yu;Olga Corti;Bertrand Mollereau

  • Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives.

    Anthony H V Schapira;C Warren Olanow;J Timothy Greenamyre;Erwan Bezard;Erwan Bezard

  • Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders

    Valerie Voon;Pierre-Olivier Fernagut;Jeff Wickens;Christelle Baunez

  • Presymptomatic compensation in Parkinson's disease is not dopamine-mediated

    Erwan Bezard;Christian E. Gross;Jonathan M. Brotchie

  • The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders.

    L. Leriche;Erwan Bezard;C. Gross;O. Guillin

  • Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration

    Benjamin Dehay;Alfredo Ramirez;Marta Martinez-Vicente;Celine Perier

  • Spatiotemporal neuromodulation therapies engaging muscle synergies improve motor control after spinal cord injury

    Nikolaus Wenger;Nikolaus Wenger;Eduardo Martin Moraud;Jerome Gandar;Pavel Musienko

  • Novel pharmacological targets for the treatment of Parkinson's disease

    Anthony H V Schapira;Erwan Bezard;Jonathan Brotchie;Frédéric Calon

  • Lysosomal impairment in Parkinson's disease.

    Benjamin Dehay;Marta Martinez-Vicente;Guy A. Caldwell;Kim A. Caldwell

Frequent Co-Authors

Qin Li
Qin Li Peking Union Medical College Hospital
Christian E. Gross
Christian E. Gross University of Bordeaux
Pierre-Olivier Fernagut
Pierre-Olivier Fernagut University of Poitiers
Wassilios G. Meissner
Wassilios G. Meissner University of Bordeaux
Alan R. Crossman
Alan R. Crossman University of Manchester
Bernard Bioulac
Bernard Bioulac University of Bordeaux
Jonathan M. Brotchie
Jonathan M. Brotchie University Health Network
Grégoire Courtine
Grégoire Courtine École Polytechnique Fédérale de Lausanne
Jose A. Obeso
Jose A. Obeso CEU San Pablo University
Laurent Cognet
Laurent Cognet University of Bordeaux

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine does not always follow a traditional path. Many students increasingly explore alternative health-related degrees and career options through flexible online study. For those interested in mental health, pmhnp online programs offer a fast-track route to becoming a Psychiatric Mental Health Nurse Practitioner, a role in high demand nationwide.

Beyond clinical roles, healthcare administration is another sector with strong growth. Earning a health care administration degree online can open doors to management, policy, and leadership positions in hospitals and health organizations. Those seeking to minimize costs can investigate the cheapest master's in healthcare administration to gain essential skills without a significant financial burden.

If your goal is to reach the highest level of nursing practice, consider the cheapest dnp online programs to pursue a Doctor of Nursing Practice degree. These online options make advanced education more accessible, helping students balance studies with their current professional or personal commitments.

Best Scientists Citing Erwan Bezard

Trending Scientists

Recently Published Articles